DOW JONES25,766.64-1190.95 -4.42%
S&P 5002,978.76-137.63 -4.42%
NASDAQ8,566.48-414.30 -4.61%

GlaxoSmithKline Reports FDA Grants Priority Review Of Belantamab Mafodotin For Patients With Relapsed, Refractory Multiple Myeloma

Benzinga · 01/21/2020 14:01